ZNF117 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.808000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.566500E-02
Normal-vs-Stage2
2.207400E-01
Normal-vs-Stage3
3.995100E-03
Normal-vs-Stage4
4.224000E-01
Stage1-vs-Stage2
3.310200E-01
Stage1-vs-Stage3
2.583400E-01
Stage1-vs-Stage4
2.561400E-01
Stage2-vs-Stage3
6.382600E-03
Stage2-vs-Stage4
3.691200E-01
Stage3-vs-Stage4
1.910830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.203400E-01
Normal-vs-AfricanAmerican
1.571630E-01
Normal-vs-Asian
5.003600E-01
Caucasian-vs-AfricanAmerican
4.999400E-01
Caucasian-vs-Asian
6.633000E-01
AfricanAmerican-vs-Asian
6.832000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.680600E-01
Normal-vs-Female
4.344000E-02
Male-vs-Female
3.241200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.448000E-01
Normal-vs-Age(41-60Yrs)
7.241200E-01
Normal-vs-Age(61-80Yrs)
6.998300E-03
Normal-vs-Age(81-100Yrs)
4.612000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.590800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.352400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.511400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.460060E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.212200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.148620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.111000E-01
Normal-vs-Daily Drinker
3.308600E-01
Normal-vs-Weekly Drinker
3.480200E-01
Normal-vs-Occasional Drinker
8.962200E-01
Normal-vs-Social Drinker
8.839200E-01
Non Drinker-vs-Daily Drinker
6.581800E-01
Non Drinker-vs-Weekly Drinker
3.420000E-01
Non Drinker-vs-Occasional Drinker
6.042600E-01
Non Drinker-vs-Social Drinker
7.803400E-01
Daily Drinker-vs-Weekly Drinker
6.862800E-01
Daily Drinker-vs-Occasional Drinker
4.358000E-01
Daily Drinker-vs-Social Drinker
5.597200E-01
Weekly Drinker-vs-Occasional Drinker
2.335000E-01
Weekly Drinker-vs-Social Drinker
2.735200E-01
Occasional Drinker-vs-Social Drinker
8.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.942400E-01
Normal-vs-Grade 2
2.047200E-01
Normal-vs-Grade 3
9.561800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.799790E-01
Grade 1-vs-Grade 3
2.993500E-02
Grade 1-vs-Grade 4
2.942400E-01
Grade 2-vs-Grade 3
3.084200E-01
Grade 2-vs-Grade 4
2.047200E-01
Grade 3-vs-Grade 4
9.561800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.267800E-01
Normal-vs-NonDiabetic
2.933400E-01
Diabetic-vs-NonDiabetic
5.936300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.313400E-01
Normal-vs-NoPancreatitis
5.275700E-02
Pancreatitis-vs-NoPancreatitis
1.588960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.171600E-01
Normal-vs-N1
1.412230E-01
N0-vs-N1
8.225000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.166000E-01
Normal-vs-TP53-NonMutant
3.628000E-02
TP53-Mutant-vs-TP53-NonMutant
1.628780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
